Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
03.01.2023
XORTX Files New Provisional Patent to Diagnose and Treat Individuals Most at Risk of Polycystic Kidney Disease Progression
19.12.2022
XORTX Announces Completion of Dosing in XRX-OXY-101 Clinical Study
08.12.2022
XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
28.11.2022
XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study
16.11.2022
XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer
04.11.2022
XORTX Presents New Proof of Concept Data at American Society of Nephrology
03.11.2022
XORTX Announces Participation at Upcoming Investor Conferences
26.10.2022
XORTX Receives Further No Objection Letter from Health Canada
25.10.2022
XORTX Sponsored American Society of Nephrology Study Abstract Available Online
10.10.2022
XORTX Announces Closing of US$5 Million Public Offering
First
Previous
1
2
3
4
5
6
7
Next
Last